Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Regular ✕Axis ESG Integration Strategy Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCAxis
NAV₹22.8170₹21.0800
NAV date20 Nov 202620 Nov 2026
History3.1 years6.8 years
Expense ratio2.1%2.6%
Stars★★★★★★★★★★
Growth Score93.9028.20

Returns

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
1 month+12.87%+6.63%
3 months+6.85%−0.38%
6 months+17.20%+3.89%
YTD+32.43%−3.88%
1 year+30.73%−3.92%
3 years (CAGR)+29.16%+7.49%
5 years (CAGR)—+4.29%
10 years (CAGR)——
Since launch+30.28%+11.50%

Risk

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
Volatility15.8%14.0%
Downside volatility8.6%10.4%
Sharpe1.440.07
Sortino2.640.10
Calmar1.940.40
Return / risk1.850.53
Deepest fall−15.07%−25.09%
Days to recover133531
Below its high+0.00%−9.45%

Against benchmark

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
Alpha+6.36%—
Beta0.97—
R²85.0%—
Up capture106.7%—
Down capture74.4%—
Tracking error6.1%—
Information ratio0.97—
Treynor0.22—

Consistency

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
Best 1-year+64.96%+67.94%
Middle 1-year+21.84%+8.07%
Worst 1-year+0.52%−17.67%
1-year periods with a loss0.0%31.3%
Middle 3-year+28.68%+11.69%
Positive months69.4%63.9%
Best day+3.19%+3.73%
Worst day−3.62%−3.59%
Worst 5% day−1.50%−1.23%
Positive days58.1%51.4%
NAVs a year247251

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
5-year XIRR—+6.26%
5-year value—₹7,05,168
3-year XIRR+26.26%+2.23%
1-year XIRR+39.84%+1.90%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth